NCT06483919View on ClinicalTrials.gov

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

228

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions

Small-cell Lung Cancer

Trial Locations (1)

250000

Shandong Cancer Hospital and Institute, Jinan

All Listed Sponsors

lead

Jinming Yu

OTHER